Physician profile
Alberto Carli
NPI 1093119760
$64,527.33
in general payments reported to CMS, 2019-2025
13 companies · $30K in 2025
The $30K reported for 2025 was more than what 85% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,647 · 2020: $7,854 · 2021: $2,752 · 2022: $2,463 · 2023: $10K · 2024: $7,884 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $3,144 · Food and Beverage: $2,248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $29,845.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,575.00 |
| Travel and Lodging | $3,143.71 |
| Food and Beverage | $2,248.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $23,342.41 | 2025 | Celleraterx, Biasurge |
| Heraeus Medical, LLC. | $21,620.62 | 2020-2023 | Palacos |
| Zimmer Biomet Holdings, INC. | $13,339.64 | 2022-2025 | Synovasure Alpha Defensin, Rosa, Comprehensive Shoulder System |
| Kci USA, INC. | $1,933.63 | 2019-2023 | Prevena Restor Arthroform, Prevena Restor Rotoform, Prevena Restor Bellaform |
| Globus Medical, INC. | $1,906.06 | 2024-2025 | Proven Gen-Flex Ps Knee System |
| Bone Support INC. | $1,000.00 | 2019 | |
| Stryker Corporation | $460.89 | 2019 | |
| Linkbio Corp | $371.05 | 2023-2024 | |
| Medtronic USA, INC. | $177.68 | 2019 | |
| Next Science LLC | $132.07 | 2021 | |
| Exactech, INC. | $125.00 | 2019 | |
| Ortho Development Corporation | $82.88 | 2021 | |
| Depuy Synthes Sales INC. | $35.40 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Carli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.